UKRAINE - 2021/04/20: In this photo illustration a Johnson Controls logo is seen on a smartphone and ... [+] a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images Johnson Controls stock (NYSE: HUM) currently trades around $70 per share, compared to its peak levels of over $80 seen in January 2022. While the company's stock has shed more than 10% of its value, Carrier stock (NYSE: CARR) has risen around 40% over the same period. J ...

GERMANY - 2024/02/16: In this photo illustration, a Humana Inc. logo seen displayed on a tablet. ... [+] (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over the same period. HUM stock was trading at around $460 in June 2022, just before the Fed s ...

NEW YORK, Aug. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behalf of long-term stockholders following a class action complaint that was filed against Humana on June 3, 2024 with a Class Period from July 27, 2022, to January 24, 2024. Our investigation concerns whether the board of directors of Humana have breached their fiduciary duties to the company. Humana is a health in ...

If you suffered losses exceeding $100,000 investing in Humana stock or options between July 27, 2022 and January 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/HUM. NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Humana Inc. ("Humana" or th ...

Humana Inc. NYSE: HUM is a leading health insurer predominantly focused on Medicare Advantage plans, serving millions of individuals and families nationwide. The company's business model centers on offering a comprehensive range of health insurance products, including Medicare, Medicaid, individual, and employersponsored plans, along with a growing portfolio of healthcare services. Humana's earnings report for the second quarter of 2024 has generated market buzz, but the news wasn't all positive. Despite ex ...

Humana Inc. (HUM) posted second-quarter 2024 adjusted earnings per share (EPS) of $6.96, which surpassed the Zacks Consensus Estimate by 18.2%. However, the bottom line fell 22.1% year over year. Adjusted revenues improved 14.2% year over year to $29.4 billion. The top line beat the consensus mark by 2.6%. The quarterly results benefited from strong premium growth and increased service revenues, driven by expanding Medicare Advantage membership and an improved Primary Care business. However, the upside was ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | |------------------------------------------------------------------------| | | | For the transition period from to | | Commission file number 1-5975 | | HUMANA INC. | | (Exa ...

Humana, Inc. (NYSE:HUM) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations James Rechtin - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Conference Call Participants Ann Hynes - Mizuho Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Justin Lake - Wolfe Research David Windley - Jefferies A.J. Rice - UBS Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Ben Hendrix - RBC Capital Ma ...

Humana (HUM) came out with quarterly earnings of $6.96 per share, beating the Zacks Consensus Estimate of $5.89 per share. This compares to earnings of $8.94 per share a year ago. These figures are adjusted for nonrecurring items. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Humana shares have lost about 11.6% since the beginning of the year versus the S&P 500's gain of 14%. There are no easy answers to this key question, but one reliable measure that can help ...

FOR MORE INFORMATION CONTACT: • Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis • Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent • Raises 2024 individual Medicare Advantage annual membership growth by 75, ...